129 related articles for article (PubMed ID: 30255816)
21. Relationship between tumor and peripheral blood NPRL2 mRNA levels in patients with colorectal adenoma and colorectal cancer.
Liu AY; Liu DG; Du YJ; Pei FH; Yang G; Liu BR; Zhang HT; Wang XH; Fan YJ; Chen YZ; Jiang Y; Chen J
Cancer Biol Ther; 2014 May; 15(5):489-95. PubMed ID: 24521741
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer.
Leman ES; Schoen RE; Magheli A; Sokoll LJ; Chan DW; Getzenberg RH
Clin Cancer Res; 2008 Mar; 14(5):1349-54. PubMed ID: 18316554
[TBL] [Abstract][Full Text] [Related]
23. Matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in the diagnosis of colorectal adenoma and cancer patients.
Groblewska M; Mroczko B; Gryko M; Kędra B; Szmitkowski M
Folia Histochem Cytobiol; 2010 Dec; 48(4):564-71. PubMed ID: 21478099
[TBL] [Abstract][Full Text] [Related]
24. A novel methodology for in vivo endoscopic phenotyping of colorectal cancer based on real-time analysis of the mucosal lipidome: a prospective observational study of the iKnife.
Alexander J; Gildea L; Balog J; Speller A; McKenzie J; Muirhead L; Scott A; Kontovounisios C; Rasheed S; Teare J; Hoare J; Veselkov K; Goldin R; Tekkis P; Darzi A; Nicholson J; Kinross J; Takats Z
Surg Endosc; 2017 Mar; 31(3):1361-1370. PubMed ID: 27501728
[TBL] [Abstract][Full Text] [Related]
25. Detection of colorectal neoplasia: Combination of eight blood-based, cancer-associated protein biomarkers.
Wilhelmsen M; Christensen IJ; Rasmussen L; Jørgensen LN; Madsen MR; Vilandt J; Hillig T; Klaerke M; Nielsen KT; Laurberg S; Brünner N; Gawel S; Yang X; Davis G; Heijboer A; Martens F; Nielsen HJ
Int J Cancer; 2017 Mar; 140(6):1436-1446. PubMed ID: 27935033
[TBL] [Abstract][Full Text] [Related]
26. Plasma matrix metalloproteinase 9 as an early surrogate biomarker of advanced colorectal neoplasia.
Gimeno-García AZ; Triñanes J; Quintero E; Salido E; Nicolás-Pérez D; Adrián-de-Ganzo Z; Alarcón-Fernández O; Abrante B; Romero R; Carrillo M; Ramos L; Alonso I; Ortega J; Jiménez A
Gastroenterol Hepatol; 2016; 39(7):433-41. PubMed ID: 26601990
[TBL] [Abstract][Full Text] [Related]
27. CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients.
Zhu X; Qiao Y; Liu W; Wang W; Shen H; Lu Y; Hao G; Zheng J; Tian Y
Tumour Biol; 2016 Apr; 37(4):4569-77. PubMed ID: 26503215
[TBL] [Abstract][Full Text] [Related]
28. Association Between Natural Killer Cell Activity and Colorectal Cancer in High-Risk Subjects Undergoing Colonoscopy.
Jobin G; Rodriguez-Suarez R; Betito K
Gastroenterology; 2017 Oct; 153(4):980-987. PubMed ID: 28625834
[TBL] [Abstract][Full Text] [Related]
29. Colonic expression of heme oxygenase-1 is associated with a better long-term survival in patients with colorectal cancer.
Becker JC; Fukui H; Imai Y; Sekikawa A; Kimura T; Yamagishi H; Yoshitake N; Pohle T; Domschke W; Fujimori T
Scand J Gastroenterol; 2007 Jul; 42(7):852-8. PubMed ID: 17558910
[TBL] [Abstract][Full Text] [Related]
30. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
31. Fibrosis and Mast Cells in Colorectal Lesions: Significance in Adenoma-Colorectal Cancer Sequence and Association with Diet.
Alves IS; Coser PH; Loureiro GJ; Nogueira da Gama LP; Ribeiro Fda S; Bautz WG; Coburn KL; Pacheco Mda S; da Gama de Souza LN
J Gastrointest Cancer; 2016 Sep; 47(3):278-86. PubMed ID: 27146043
[TBL] [Abstract][Full Text] [Related]
32. Association between High Levels of Circulating Chemerin and Colorectal Adenoma in Men.
Yagi M; Sasaki Y; Abe Y; Yaoita T; Sakuta K; Mizumoto N; Shoji M; Onozato Y; Kon T; Nishise S; Ueno Y
Digestion; 2020; 101(5):571-578. PubMed ID: 31269491
[TBL] [Abstract][Full Text] [Related]
33. Low HtrA1 expression in patients with long‑standing ulcerative colitis and colorectal cancer.
Altobelli E; Latella G; Morroni M; Licini C; Tossetta G; Mazzucchelli R; Profeta VF; Coletti G; Leocata P; Castellucci M; Guerrieri M; Petrocelli R; De Berardis B; De Padova M; Di Leonardo G; Paladini A; Mignosi F; Quaglione G; Fagnano R; Marzioni D
Oncol Rep; 2017 Jul; 38(1):418-426. PubMed ID: 28586045
[TBL] [Abstract][Full Text] [Related]
34. Pretreatment serum levels of hematopoietic cytokines in patients with colorectal adenomas and cancer.
Mroczko B; Szmitkowski M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B
Int J Colorectal Dis; 2007 Jan; 22(1):33-8. PubMed ID: 16520929
[TBL] [Abstract][Full Text] [Related]
35. Genetic variants at chromosome 8q24, colorectal epithelial cell proliferation, and risk for incident, sporadic colorectal adenomas.
Yang B; Thyagarajan B; Gross MD; Goodman M; Sun YV; Bostick RM
Mol Carcinog; 2014 Feb; 53 Suppl 1():E187-92. PubMed ID: 23776012
[TBL] [Abstract][Full Text] [Related]
36. Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting.
Chen H; Werner S; Butt J; Zörnig I; Knebel P; Michel A; Eichmüller SB; Jäger D; Waterboer T; Pawlita M; Brenner H
Oncotarget; 2016 Mar; 7(13):16420-32. PubMed ID: 26909861
[TBL] [Abstract][Full Text] [Related]
37. [Relationship between the expression of DDX39 protein and prognosis of colorectal cancer].
Ma J; Chang W; Zhang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Mar; 21(3):336-341. PubMed ID: 29577224
[TBL] [Abstract][Full Text] [Related]
38. MAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomas.
Taguchi A; Rho JH; Yan Q; Zhang Y; Zhao Y; Xu H; Tripathi SC; Wang H; Brenner DE; Kucherlapati M; Kucherlapati R; Boutin AT; Wang YA; DePinho RA; Feng Z; Lampe PD; Hanash SM
Cancer Prev Res (Phila); 2015 Nov; 8(11):1112-9. PubMed ID: 26342024
[TBL] [Abstract][Full Text] [Related]
39. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
[TBL] [Abstract][Full Text] [Related]
40. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
